Inactive Instrument

Greenlight Biosciences Holdings Pbc Stock

GRNA

US39536G1058

Chart Greenlight Biosciences Holdings Pbc

Duration

Period

Style

Dynamic Chart

Latest news about Greenlight Biosciences Holdings Pbc

GreenLight Biosciences Completes Going Private Transaction	23-07-24	MT
Canaccord Genuity Downgrades GreenLight Biosciences to Hold From Buy, Adjusts Price Target to $0.30 From $4	23-05-31	MT
GreenLight Biosciences Agrees to be Acquired by Fall Line Capital-Led Group in $45.5 Million Deal	23-05-30	MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q1 Revenue $3.8M	23-05-11	MT
GreenLight Biosciences Gets Interest Indication From Fall Line Endurance Fund; Shares Rise After-Hours	23-03-30	MT
Greenlight Biosciences Q4 EPS Loss Narrow, Revenue Rises	23-03-28	MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q4 Revenue $3M	23-03-28	MT
GreenLight Biosciences Secures Rwanda FDA Approval for COVID-19 Clinical Trial	23-02-01	MT
GreenLight Biosciences, Epivax Therapeutics to Jointly Develop Personalized Cancer Vaccines	23-01-09	MT
Canaccord Initiates GreenLight Biosciences With Buy Rating, Price Target is $4	22-12-08	MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Posts Q3 Revenue $1.7M	22-11-09	MT
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Posts Q3 Loss $-0.27	22-11-09	MT
Credit Suisse Initiates GreenLight Biosciences Holdings, Origin Materials with Outperform Ratings, Says Both Represent Next-Generation Chemical Technologies	22-10-14	MT
ETF Preview: ETFs, Futures Slightly Higher Premarket After September Producer Price Index Report	22-10-12	MT
GreenLight Biosciences to Cut Jobs, Costs as Part of Planned Realignment	22-10-12	MT

More news

Analyst Recommendations on Greenlight Biosciences Holdings Pbc

Canaccord Genuity Downgrades GreenLight Biosciences to Hold From Buy, Adjusts Price Target to $0.30 From $4	23-05-31	MT
Canaccord Initiates GreenLight Biosciences With Buy Rating, Price Target is $4	22-12-08	MT
Credit Suisse Initiates GreenLight Biosciences Holdings, Origin Materials with Outperform Ratings, Says Both Represent Next-Generation Chemical Technologies	22-10-14	MT

More recommendations

Press releases Greenlight Biosciences Holdings Pbc

GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction	23-05-30	AQ
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress	23-05-11	AQ
GreenLight Biosciences Releases Inaugural Sustainability Report	23-04-12	AQ
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-03-30	AQ

More press releases

News in other languages on Greenlight Biosciences Holdings Pbc

GREENLIGHT BIOSCIENCES : vers une entrée en bourse via un SPAC	21-08-11
Planète Bourse : La revue de presse du mercredi 11 août 2021	21-08-11

More news

Environmental Impact Acquisition Corp is a blank check company. The Company's business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus on sectors, including smart building technologies, smart grid and smart city, energy efficiency & decarbonization, renewable energy & distributed generation, electric vehicles & mobility, agriculture & food technology, recycling & remediation, and water & bioresources. It is neither engaged in any operations nor generated any revenues.

Sector

More about the company